Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes.
Marta Garcia-GuixAlba ArdèvolVictor SapenaEdilmar AlvaradoAnna HuertasAnna BrujatsJavier FajardoBerta CuyasMaría PocaCarlos GuarnerXavier TorrasÀngels EscorsellCàndid VillanuevaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
In each stage of decompensated cirrhosis, mortality risk significantly and very markedly increase with further-decompensation. HVPG-non-response to NSBBs may adequately stratify the risk of further decompensation and death, in each stage. This suggests potential benefit with pre-emptive therapies in HVPG-non-responders at each-stage.